Aurobindo Pharma informs about press release

19 Jul 2017 Evaluate

Aurobindo Pharma has informed about a press release titled ‘Aurobindo Pharma receives USFDA Approval for Sevelamer Carbonate tablets’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1183.95 -15.90 (-1.33%)
31-May-2024 13:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1443.00
Dr. Reddys Lab 5824.10
Cipla 1458.95
Zydus Lifesciences 1004.15
Lupin 1582.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.